HPV Infection Prevention

Translate to Spanish or other 102 languages!

Most HPV infections (9 out of 10) go away by themselves within 2 years. But sometimes, HPV infections will last longer and can cause some cancers.  Image for illustration purposes
Most HPV infections (9 out of 10) go away by themselves within 2 years. But sometimes, HPV infections will last longer and can cause some cancers. Image for illustration purposes
- Advertisement -

HPV, or human papillomavirus, is a common virus that can cause cancers later in life. You can protect your child from these cancers with HPV vaccine at age 11–12 years.

HPV infections are common

HPV infections are very common. Nearly everyone will get HPV at some point in their lives.

  • More than 42 million Americans are infected with types of HPV that are known to cause disease.
  • About 13 million Americans, including teens, become infected each year.

HPV is spread through intimate skin-to-skin contact. You can get HPV by having vaginal, anal, or oral sex with someone who has the virus, even if they don’t have signs or symptoms.

- Advertisement -

Some HPV infections can lead to cancer

Most HPV infections (9 out of 10) go away by themselves within 2 years. But sometimes, HPV infections will last longer and can cause some cancers. HPV infections can cause cancers of the:

  • Cervix, vagina, and vulva
  • Penis
  • Anus
  • Back of the throat (called oropharyngeal cancer), including the base of the tongue and tonsils

Every year in the United States, HPV causes about 36,000 cases of cancer in both men and women.

Prevent cancer with HPV vaccine

CDC recommends two doses of HPV vaccine at ages 11–12 years. HPV vaccination can be started at age 9 years.

Children who get the first dose before their 15th birthday only need two doses. Teens who get the first dose on or after their 15th birthday need three doses.

- Advertisement -

The HPV vaccine series is most effective when given before a person is exposed to the virus.

Information Source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

Three Everyday Habits That Could Be Ruining Your Sleep

 If you struggle to get a good night’s sleep, you may want to look at some of your habits – like what time you actually go to bed.

When GLP‑1s Fall Short

Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Source have been growing in popularity for not only treating type 2 diabetes but also for weight loss. 
- Advertisement -